
Shares of hospital chain operator Shalby SHAY.NS rise as much as 4.9% to 233.65 rupees; currently up 2.6%
Co on Wednesday said its U.S. unit received U.S. FDA clearance for DuraniomTM, its primary total knee replacement device
Stock on track for a third consecutive session of gains, if trend holds
SHAY fell 24.1% in 2024, snapping four straight years of gains
(Reporting by Ashish Chandra in Bengaluru)
((ashish.chandra@thomsonreuters.com (+91 7982114624))